原发性血小板增多症不典型CALR突变1例

[1]	鞠满凯, 付荣凤, 李慧媛, 等.三阴性血小板增多症的患者特点及靶向基因测序分析[J].中国实验血液学杂志, 2018, 26(4):1137-1145. http://d.old.wanfangdata.com.cn/Periodical/zgsyxyxzz201804032
[2]	Xing CY, Li HY, Wu JB, et al. Cooccurrence of JAK2 V617F and an uncommon CALR del (p.K368fs51) mutation facilitates JAK2/STAT signaling in polycythemia vera[J]. Leukemia & Lymphoma, 2015, 57(7): 1743-1745. doi: 10.3109/10428194.2015.1115031
[3]	Kollmann K, Nangalia J, Warsch W, et al. MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling[J]. Leukemia, 2015, 29(2):494-497. doi: 10.1038/leu.2014.285
[4]	Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis[J]. Blood, 2014, 124(16):2507- 2513. doi: 10.1182/blood-2014-05-579136